Tag Archives: Diabetes mellitus

Judgment Day for Avandia

By Oriana Schwindt | Published: July 14, 2010
Judgment Day has finally arrived for GSK’s Avandia. FDA’s Endocrinologic and Metabolic Drugs and Drug Safety and Risk Management Advisory Committees met July 13 and 14 to finally recommend, after months of deck-stacking against GSK, that the drug be severely restricted, if not outright pulled from the market. In the vote, 12 of 33 panelists [...]
Posted in FDA, Regulatory | Also tagged , , , , , , | Leave a comment

FDA to Review Prostate Cancer Meds

By George Koroneos | Published: May 4, 2010
Image via Wikipedia FDA, on Monday, announced that it was reviewing whether a certain class of prostate cancer drugs could lead to diabetes, stroke, death, or heart problems. The drugs in question are gonadotropin-Releasing Hormone (GnRH) agonists, marketed under a number of monikers, including Vantas and Lupron. These treatments are used to slow the growth of prostate [...]
Posted in FDA, Safety | Also tagged , , , , , , | Leave a comment

Reps Allowed Access; Just Make an Appointment

By George Koroneos | Published: March 17, 2010
Image by Joseph Cote via Flickr SK&A released the results of its latest physician survey, and it turns out that most docs are happy to meet with sales reps as long as they make an appointment in advance. In fact, 98 percent of offices that allow sales reps to make office calls see 20 reps per week. “That’s [...]
Posted in Sales | Also tagged , , , , , , , , | 1 Comment

Statins Get Boost from New Study

By Sarah Houlton | Published: July 22, 2009
Image via Wikipedia Statins should be given to people with high blood pressure or diabetes, even if they don’t have heart disease, according to a study published in the British Medical Journal. While several studies have shown that statins benefit those with cardiovascular disease, this is the first large study which looked at statins as primary [...]
Posted in News, Strategy | Also tagged , , , , , , | Leave a comment